The proposed acquisition would hand Servier a couple experimental drugs in human testing as well as Ojemda, an approved therapy for certain hard-to-treat brain tumors that affect children. Source link
The Federal Reserve may cut short-term borrowing costs again in June after government data showed the economy shed jobs last...
- Advertisement - A free digital application called “Sustainability Career Pathfinder” has been launched by Comfort Apeh Francis, the United...
India’s PC market had its strongest year on record in 2025, surpassing the surge in demand during the COVID-19 pandemic...
The 2009 Union Buildings protest march by soldiers remains on hold in the courts with a Tuesday appearance leading only...
Young people across Africa have turned against ageing liberation parties for failing to deliver on their promises, Mozambique’s firebrand opposition...
On the hunt for a fresh pair of headphones that stand out in the style department? Until the end of...
Scaling intelligent automation without disruption demands a focus on architectural elasticity, not just deploying more bots.At the Intelligent Automation Conference,...
